Skip to Content

Zamansky LLC Investigates The UBS Carlyle I and II Funds

July 17, 2013 Blog

Zamansky LLC is investigating the UBS Carlyle Fund I, LLC and UBS Carlyle Fund II, LLC (“UBS Carlyle”), private investment funds sold by UBS Financial Services Inc. (“UBS Financial Services”) and its financial advisors to the firm’s brokerage customers.

According to filings with the U.S. Securities & Exchange Commission (“SEC”), available at, on October 11, 2007, UBS Carlyle II filed a Form D disclosing that it had sold $62.275 million of limited liability company interests. UBS Financial Services is listed as the “sponsor” in this Form D.

Zamansky is investigating sales of the UBS Carlyle Funds to investors. According to hedge fund fraud attorney Jake Zamansky, “private investments are inherently risky and not appropriate or suitable for conservative or other risk-averse investors. Any investor who purchased one of these funds but who did not want to invest in high risk investments may have legal recourse.”

What Fund Investors Can Do

If you invested in the UBS Carlyle Funds and would like to us to review your investments or discuss your legal rights, you may, without obligation or cost to you, email or call the law firm at (212) 742-1414.

About Zamansky LLC

Zamansky LLC are leading stock market fraud lawyers, specializing in securities arbitration and securities class action litigation. Our FINRA attorneys represent both individual and institutional investors in claims of stock broker fraud. Our securities arbitration practice is nationally recognized for our ability to aggressively prosecute cases and recover losses.


To learn more about Zamansky, please visit our website,


Zamansky & Associates, LLC
50 Broadway – 32nd Floor
New York, NY 10004
Jake Zamansky, 212-742-1414